GlobeNewswire: Emblem Corp. Contains the last 10 of 68 releaseshttp://www.globenewswire.com/External?Length=42024-03-29T10:45:43ZGlobeNewswirehttp://www.globenewswire.com/External?Length=4newsdesk@globenewswire.com (NewsDesk)https://www.globenewswire.com/news-release/2019/03/08/1750792/0/en/Emblem-Receives-Final-Order-Approving-Arrangement-With-Aleafia.html?f=22&fvtc=4&fvtv=34261Emblem Receives Final Order Approving Arrangement With Aleafia2019-03-08T18:36:30Z<![CDATA[TORONTO, March 08, 2019 (GLOBE NEWSWIRE) -- Emblem Corp. (TSXV: EMC, OTCQX: EMMBF) (“Emblem” or the “Company”) is pleased to announce that it has received a final order from the Ontario Superior Court of Justice (Commercial List) approving the previously announced plan of arrangement (the “Arrangement”) with Aleafia Health Inc. (“Aleafia”) described in the joint press release issued by Emblem and Aleafia on December 19, 2018.]]>https://www.globenewswire.com/news-release/2019/03/06/1749117/0/en/Emblem-Corp-Shareholders-Approve-Proposed-Arrangement-with-Aleafia-Health-Announces-Results-of-Special-Meeting.html?f=22&fvtc=4&fvtv=34261Emblem Corp. Shareholders Approve Proposed Arrangement with Aleafia Health, Announces Results of Special Meeting2019-03-06T19:08:33Z<![CDATA[TORONTO, March 06, 2019 (GLOBE NEWSWIRE) -- Emblem Corp. (TSXV: EMC, OTCQX: EMMBF) (“Emblem” or the “Company”) is pleased to announce that, at the special meeting of shareholders of Emblem held today (the “Meeting”), the shareholders of Emblem voted in favour of a special resolution to approve the proposed arrangement (the “Arrangement”) involving Emblem and Aleafia Health described in the joint press release issued by Emblem and Aleafia on December 19, 2018, as well as certain other Meeting matters.]]>https://www.globenewswire.com/news-release/2019/02/05/1711000/0/en/Emblem-Corp-Announces-Receipt-of-Interim-Court-Order-and-Mailing-of-Meeting-Materials-Related-to-its-Special-Meeting-of-Shareholders-and-Proposed-Arrangement-with-Aleafia-Health-In.html?f=22&fvtc=4&fvtv=34261Emblem Corp. Announces Receipt of Interim Court Order and Mailing of Meeting Materials Related to its Special Meeting of Shareholders and Proposed Arrangement with Aleafia Health Inc.2019-02-05T21:05:00Z<![CDATA[TORONTO, Feb. 05, 2019 (GLOBE NEWSWIRE) -- Emblem Corp. (TSXV: EMC, OTCQX: EMMBF) (“Emblem” or the “Company”) announces that the Ontario Superior Court of Justice (Commercial List) granted the Company’s motion for an interim order authorizing various matters, including the mailing of a management information circular (the “Circular”) and the holding of the special meeting of Emblem shareholders to be held on Wednesday March 6, 2019 at 10:30 a.m. (Toronto time) at the offices of Dentons Canada LLP, 77 King Street West, Suite 400, Toronto, Ontario, M5K 0A1 (the “Meeting”).]]>https://www.globenewswire.com/news-release/2019/01/08/1682071/0/en/Emblem-Oils-Now-Available-Through-Shoppers-Drug-Mart.html?f=22&fvtc=4&fvtv=34261Emblem Oils Now Available Through Shoppers Drug Mart2019-01-08T13:55:00Z<![CDATA[TORONTO, Jan. 08, 2019 (GLOBE NEWSWIRE) -- Emblem Corp. (TSXV: EMC, OTCQX: EMMBF) (“Emblem” or the “Company”) through its wholly-owned subsidiary Emblem Cannabis Corporation, today announced that Emblem-branded cannabis oils are now available online through Shoppers Drug Mart to patients with a valid medical authorization.]]>https://www.globenewswire.com/news-release/2018/12/19/1669388/0/en/Aleafia-Health-Inc-to-Acquire-Emblem-Corp-to-Create-New-Medical-Cannabis-Leader.html?f=22&fvtc=4&fvtv=34261Aleafia Health Inc. to Acquire Emblem Corp. to Create New Medical Cannabis Leader 2018-12-19T12:19:45Z<![CDATA[TORONTO, Dec. 19, 2018 (GLOBE NEWSWIRE) -- Aleafia Health Inc. (TSXV: ALEF) (“Aleafia” or the “Company”) and Emblem Corp. (TSXV: EMC, OTCQX: EMMBF) (“Emblem”) are pleased to announce that they have entered into a definitive agreement (the “Agreement”) under which Aleafia will acquire, by way of a plan of arrangement under the Canada Business Corporations Act, all of Emblem’s issued and outstanding common shares in an all-share transaction currently valued at approximately $173.2 Million (the “Transaction”).]]>https://www.globenewswire.com/news-release/2018/12/10/1664221/0/en/Emblem-launches-new-line-of-Oil-Capsules.html?f=22&fvtc=4&fvtv=34261Emblem launches new line of Oil Capsules2018-12-10T11:30:00Z<![CDATA[Capsules are latest addition to the Company’s growing line of innovative medical cannabis products Capsules are latest addition to the Company’s growing line of innovative medical cannabis products]]>https://www.globenewswire.com/news-release/2018/11/20/1654325/0/en/Emblem-Corp-Reports-Strong-Third-Quarter-2018-Financial-Results.html?f=22&fvtc=4&fvtv=34261Emblem Corp. Reports Strong Third Quarter 2018 Financial Results 2018-11-20T11:30:00Z<![CDATA[Revenues increase 281% over the quarter ended September 30, 2017 and 50% over Q2 2018]]>https://www.globenewswire.com/news-release/2018/11/07/1646830/0/en/Emblem-Corp-announces-new-board-appointments.html?f=22&fvtc=4&fvtv=34261Emblem Corp. announces new board appointments2018-11-07T12:00:00Z<![CDATA[TORONTO, Nov. 07, 2018 (GLOBE NEWSWIRE) -- Emblem Corp. (TSXV: EMC, OTCQX: EMMBF) (“Emblem” or the “Company”) today announced the appointment of Connie A. Stefankiewicz and Loreto Grimaldi to its Board of Directors (the “Board”) following Emblem’s annual and special shareholders’ meeting. Harvey Shapiro, current chair, and Maxim Zavet have stepped down from the Board, and the Board would like to thank them for their immense contributions since Emblem’s inception. Ms. Stefankiewicz and Mr. Grimaldi will join current Board members Daniel Milliard, Jeffrey Fineberg, John H. Stewart, Terry Johnson and Nick Dean. In connection with the resignation of Mr. Shapiro, the Board has appointed independent director Mr. Milliard as the new chair of the Board.]]>https://www.globenewswire.com/news-release/2018/10/24/1626103/0/en/Emblem-finalizes-agreement-to-launch-Emblem-Germany-in-joint-venture-with-Acnos-Pharma.html?f=22&fvtc=4&fvtv=34261Emblem finalizes agreement to launch Emblem Germany in joint venture with Acnos Pharma2018-10-24T10:30:00Z<![CDATA[Agreement will see Emblem export to one of the world’s largest legal medical cannabis markets]]>https://www.globenewswire.com/news-release/2018/10/15/1621567/0/en/Emblem-Establishes-Temporary-Patient-Access-Investment-Fund-to-Partially-Cover-Medical-Cannabis-Excise-Tax.html?f=22&fvtc=4&fvtv=34261Emblem Establishes Temporary “Patient Access Investment Fund” to Partially Cover Medical Cannabis Excise Tax2018-10-15T20:41:42Z<![CDATA[Emblem will continue to advocate against the application of any tax on medical cannabis]]>